HOME > ARCHIVE
ARCHIVE
- Takara Bio: Takara FLT3/ITD Mutation Detection Set
February 10, 2003
- 5 More Wholesalers to Invest in Information Supplier SAFE
February 10, 2003
- Eiken Licenses LAMP Method to Nippon Gene
February 10, 2003
- BUSINESS NEWS IN BRIEF
February 10, 2003
- Sysmex to Introduce Communication Network into Europe
February 10, 2003
- WEBSITYE NEWS
February 10, 2003
- Nippon BD: BD Sheet Media
February 10, 2003
- BULLETIN
February 3, 2003
- Strategic Alliance between Olympus, ITX Corp Beefed Up
February 3, 2003
- Nippon Kayaku Gives Priority to DDS Using Nanotechnology
February 3, 2003
- New President of Laerdal Medical Japan Pledges Contribution to Emergency Care
February 3, 2003
- Local Gov't Officials Discuss Health Problems
February 3, 2003
- MEDICAL DEVICE NEWS IN BRIEF
February 3, 2003
- Nagano Gov't Proposes Hospitals Operated by Stock Company
February 3, 2003
- Nissui Developing Combined Genetic, Immunologic Test System
February 3, 2003
- METI to Promote Health Service Industries to Cut Medical Costs
February 3, 2003
- DIAGNOSTIC NEWS IN BRIEF
February 3, 2003
- Chuikyo Subcommittee to Start Talks on NHI Price System in March
February 3, 2003
- Kyowa Hakko Licenses Oral DDS Tablet Technology to Eurand
February 3, 2003
- REGULATORY NEWS IN BRIEF
February 3, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
